Sep 5
|
Arcturus Therapeutics and CSL Announce European Medicines Agency Validates Marketing Authorization Application for ARCT-154 Vaccine to Prevent COVID-19
|
Apr 27
|
OTC Markets Group Welcomes CSL Limited to OTCQX
|
Apr 25
|
CSL Seqirus Proud to Attend and Present at 2023 Canadian Immunization Conference
|